VXRT · Categories · Form 4

VXRT - SEC Form 4 insider transactions

Vaxart Inc (VXRT) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for VXRT

• 26d
  Chief Financial Officer Grasman Jeroen Nicolaas covered exercise/tax liability with 31,395 shares, decreasing direct ownership by 5% to 545,605 units (SEC Form 4) (tax liability)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 45d
  Director Breitmeyer James B was granted 78,800 shares (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 77d
  SEC Form 4 filed by Tucker Sean

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 77d
  SEC Form 4 filed by Cummings James F.

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 82d
  SEC Form 4 filed by Berg Edward B

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 82d
  SEC Form 4 filed by Cummings James F.

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 82d
  SEC Form 4 filed by Lo Steven

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 82d
  SEC Form 4 filed by Tucker Sean

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 88d
  SEC Form 4 filed by Berg Edward B

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 88d
  SEC Form 4 filed by Cummings James F.

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 88d
  SEC Form 4 filed by Lo Steven

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 88d
  SEC Form 4 filed by Tucker Sean

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 89d
  SEC Form 4 filed by Lo Steven

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 89d
  SEC Form 4 filed by Tucker Sean

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 89d
  SEC Form 4 filed by Grasman Jeroen Nicolaas

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 89d
  SEC Form 4 filed by Cummings James F.

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 89d
  SEC Form 4 filed by Berg Edward B

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 130d
  Chief Medical Officer Cummings James F. covered exercise/tax liability with 7,965 shares, decreasing direct ownership by 1% to 737,792 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 130d
  SVP, General Counsel Berg Edward B covered exercise/tax liability with 9,265 shares, decreasing direct ownership by 1% to 684,858 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 130d
  SVP, Chief Scientific Officer Tucker Sean covered exercise/tax liability with 9,265 shares, decreasing direct ownership by 1% to 731,225 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 189d
  President, Chief Exec Officer Lo Steven was granted 151,351 shares and covered exercise/tax liability with 54,153 shares, increasing direct ownership by 6% to 1,787,559 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 364d
  Director Finney Kevin was granted 6,103 shares, increasing direct ownership by 19% to 38,103 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 364d
  Director Watson W. Mark was granted 16,000 shares, increasing direct ownership by 20% to 94,125 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 364d
  Director Heron Elaine J was granted 16,000 shares, increasing direct ownership by 39% to 56,566 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 364d
  Director Wheadon David E. was granted 16,000 shares, increasing direct ownership by 52% to 46,750 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 364d
  Director Finney Michael J. was granted 16,000 shares, increasing direct ownership by 2% to 702,840 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 392d
  Chief Financial Officer Grasman Jeroen Nicolaas was granted 350,000 shares (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 440d
  Chief Medical Officer Cummings James F. covered exercise/tax liability with 3,292 shares, decreasing direct ownership by 0.44% to 745,757 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 441d
  SVP, Chief Scientific Officer Tucker Sean covered exercise/tax liability with 3,913 shares, decreasing direct ownership by 0.53% to 740,490 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 446d
  President, Chief Exec Officer Lo Steven was granted 1,405,000 shares, increasing direct ownership by 617% to 1,632,638 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 446d
  SVP, Chief Scientific Officer Tucker Sean was granted 406,000 shares, increasing direct ownership by 120% to 744,403 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 446d
  Chief Financial Officer Lee Phillip E was granted 406,000 shares, increasing direct ownership by 180% to 631,619 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 446d
  Chief Medical Officer Cummings James F. was granted 406,000 shares, increasing direct ownership by 118% to 749,049 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 446d
  SVP, General Counsel Berg Edward B was granted 406,000 shares, increasing direct ownership by 141% to 694,123 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 452d
  SVP, General Counsel Berg Edward B covered exercise/tax liability with 8,050 shares, decreasing direct ownership by 3% to 288,123 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 452d
  Chief Medical Officer Cummings James F. covered exercise/tax liability with 10,039 shares, decreasing direct ownership by 3% to 343,049 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 452d
  President, Chief Exec Officer Lo Steven covered exercise/tax liability with 22,362 shares, decreasing direct ownership by 9% to 227,638 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 452d
  SVP, Chief Scientific Officer Tucker Sean covered exercise/tax liability with 8,050 shares, decreasing direct ownership by 2% to 338,403 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 452d
  Chief Financial Officer Lee Phillip E covered exercise/tax liability with 8,050 shares, decreasing direct ownership by 3% to 225,619 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 496d
  SVP, Chief Scientific Officer Tucker Sean covered exercise/tax liability with 9,242 shares, decreasing direct ownership by 3% to 346,453 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 496d
  Chief Medical Officer Cummings James F. covered exercise/tax liability with 7,964 shares, decreasing direct ownership by 2% to 318,837 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 496d
  SVP, General Counsel Berg Edward B covered exercise/tax liability with 9,242 shares, decreasing direct ownership by 3% to 261,464 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 502d
  Director Finney Kevin was granted 32,000 shares (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 546d
  Chief Financial Officer Lee Phillip E covered exercise/tax liability with 6,132 shares, decreasing direct ownership by 3% to 233,669 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 733d
  Chief Financial Officer Lee Phillip E covered exercise/tax liability with 2,007 shares, decreasing direct ownership by 0.83% to 239,801 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 734d
  Director Wheadon David E. was granted 16,000 shares, increasing direct ownership by 108% to 30,750 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 734d
  Director Finney Michael J. was granted 16,000 shares, increasing direct ownership by 2% to 686,840 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 734d
  Director Heron Elaine J was granted 16,000 shares, increasing direct ownership by 65% to 40,566 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 734d
  Director Watson W. Mark was granted 16,000 shares, increasing direct ownership by 38% to 58,125 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 734d
  Director Yedid Robert A. was granted 16,000 shares, increasing direct ownership by 87% to 34,490 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 805d
  SEC Form 4 filed by Tucker Sean (Amendment)

  4/A - Vaxart, Inc. (0000072444) (Issuer)
• 805d
  Tucker Sean covered exercise/tax liability with 3,902 shares, decreasing direct ownership by 1% to 355,695 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 805d
  Cummings James F. covered exercise/tax liability with 3,292 shares, decreasing direct ownership by 1.00% to 326,801 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 817d
  Tucker Sean covered exercise/tax liability with 47,191 shares and was granted 90,000 shares, increasing direct ownership by 11% to 420,122 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 817d
  Lee Phillip E covered exercise/tax liability with 41,094 shares and was granted 90,000 shares, increasing direct ownership by 25% to 241,808 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 817d
  Cummings James F. covered exercise/tax liability with 39,374 shares and was granted 90,000 shares, increasing direct ownership by 18% to 330,093 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 817d
  Berg Edward B covered exercise/tax liability with 42,972 shares and was granted 90,000 shares, increasing direct ownership by 21% to 270,706 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 817d
  Lo Steven was granted 250,000 shares (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 1049d
  SEC Form 4: Watson W. Mark was granted 7,375 shares, increasing direct ownership by 21% to 42,125 units

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 1049d
  SEC Form 4: Heron Elaine J was granted 6,922 shares, increasing direct ownership by 39% to 24,566 units

  4 - Vaxart, Inc. (0000072444) (Issuer)

Other VXRT categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends